Latest news
CytomX Therapeutics Announces Date for Second Quarter 2026 Financial Results Conference Call - Quiver QuantitativeQuiver Quantitative · Thu, 30 Jul 2026 12:15:00 GMTMBX Biosciences (NASDAQ:MBX) Trading 8.5% Higher on Analyst Upgrade - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:00:00 GMTVaxcyte, Inc. $PCVX Stake Boosted by Elmind Capital LP - MarketBeatMarketBeat · Tue, 28 Jul 2026 07:00:00 GMTCG Oncology, Inc. $CGON Shares Sold by Elmind Capital LP - MarketBeatMarketBeat · Tue, 28 Jul 2026 07:00:00 GMTElmind Capital LP Has $2.65 Million Stock Position in BioMarin Pharmaceutical Inc. $BMRN - MarketBeatMarketBeat · Tue, 28 Jul 2026 07:00:00 GMT